Shares of Harley-Davidson, Colliers International, Scholar Rock Holding, Tiffany and Exact Sciences on Tuesday entered the top five gainers, significantly surpassing the performance of major index funds.
On the background of the significant drop of indices on Monday and a further decline in the S&P 500 and the Dow Jones on Tuesday, these five stocks have shown a sharp increase, causing investors ‘ optimism about their future.
1. Shares of Harley-Davidson rose sharply on huge 22% in one day
Shares of Harley-Davidson (HOG), which fell by 12.3% over the past 12 months, demonstrate a strong growth of 48% over the last month, given the growth spurt on Tuesday.
Legendary motorcycle manufacturer that is undergoing a transformation into a manufacturer of electric motorcycles, has published third quarter results, which significantly exceeded the expectations of Wall Street analysts.
Earnings per share rose to $1.05 in., exceeding the estimate of $0,28. Income though decreased by 9% compared to last year to $1.16 billion, but also exceeded the analyst estimate of $844 million improved compared to a sharp decline in the last quarter. See the quarterly history of revenue and profit Harley-Davidson for the last 2 years can link.
2. Shares of the world leader commercial real estate at Colliers International grew more than 12%
The shares of Colliers International (CIGI), which fell sharply at the beginning of the pandemic, rose after the company posted better-than-expected profit for the third quarter.
“Despite the far-reaching consequences of a pandemic, Colliers showed a better-than-expected financial results in the third quarter with continued growth through regular services. The results are Testament to the sustainability of our global platform and differentiated business model, which diversificarea by geography, services and asset classes,” said Jay S. Hennick, global Chairman and CEO of Colliers International. “Although the pandemic and geopolitical uncertainties continue, we expect our full year results will be better than previously expected”.
3. Shares of the biopharmaceutical company Scholar Rock Holding has increased by more than 118%
Stock Scholar Rock Holding (SRRK), specializing in the development and sale of innovative medicines to treat serious diseases, showed a record of historic growth after the company reported positive interim results of phase 2 study to assess an experimental drug “SRK-015” for the treatment of spinal muscular atrophy 2 and 3 type. Six months after receiving the “SRK-015” 67% of patients improved motor function for at least one point on the scale of Hammersmith.
Scholar Rock expects to publish the key data for the 12-month treatment period in phase 2 studies SRK-015 in the second quarter of 2021. The company also will soon begin negotiations with the regulatory authorities about the promotion of an experimental drug to the final stage of clinical trials.
On Tuesday, the Scholar Rock announced that it intends to conduct a secondary underwriting public offering of its shares for $150 million.
4. The company’s shares molecular diagnostics of cancer Exact Sciences grew by over 23%
Shares of Exact Sciences (EXAS) rose sharply on Tuesday after the announcement of the purchase of medical diagnostic company Thrive Earlier Detection which specializiruetsya on tests for early detection of cancer, for $2.15 billion in cash and stock.
The enthusiasm of investors was caused by the fact that the company announced the possibility of early detection of cancer through simple blood test. The market for early detection of cancer is estimated at $25 billion.
5. Tiffany shares rose nearly 5%
Shares of Tiffany (TIF), which fell by 3.6% YTD, rose on Tuesday after reports that the company and French giant LVMH luxury goods are in talks to settle the dispute about the merger in the amount of $16 billion.
After the crisis of a pandemic, LVMH made a “step back” from the previously agreed price of the transaction, after which Tiffany sued the company to court. According to anonymous sources, the parties can try a little lower price, or potentially go to bid.
